Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

NCT04893915 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding support

Conditions

Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: Cytokine-induced memory-like NK cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Donor Leukapheresis
DRUG: Interleukin-2

Sponsor

Washington University School of Medicine

Collaborators

[object Object]